Anticipating future SARS-CoV-2 variants of concern through ab initio quantum mechanical modeling

Evolved SARS-CoV-2 variants are currently challenging the efficacy of first-generation vaccines, largely through the emergence of spike protein mutants. Among these variants, Delta is presently the most concerning. We employ an ab initio quantum mechanical model based on Density Functional Theory to characterize the spike protein Receptor Binding Domain (RBD) interaction with host cells and gain mechanistic insight into SARS-CoV-2 evolution. The approach is illustrated via a detailed investigation of the role of the E484K RBD mutation, a signature mutation of the Beta and Gamma variants. The simulation is employed to: predict the depleting effect of the E484K mutation on binding the RBD with select antibodies; identify residue E484 as a weak link in the original interaction with the human receptor hACE2; and describe SARS-CoV-2 Wuhan strand binding to the bat Rhinolophus macrotis ACE2 as more optimized than the human counterpart. Finally, we predict the hACE2 binding efficacy of a hypothetical E484K mutation added to the Delta variant RBD, identifying a potential future variant of concern. Results can be generalized to other mutations, and provide useful information to complement existing experimental datasets of the interaction between randomly generated libraries of hACE2 and viral spike mutants. We argue that ab initio modeling is at the point of being aptly employed to inform and predict events pertinent to viral and general evolution.

[1]  Meden F. Isaac-Lam Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex , 2021, In Silico Pharmacology.

[2]  L. Genovese,et al.  Density functional theory calculations of large systems: Interplay between fragments, observables, and computational complexity , 2021, WIREs Computational Molecular Science.

[3]  Rommie E. Amaro,et al.  SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma , 2021, Proceedings of the National Academy of Sciences.

[4]  Helen M. Deeks,et al.  Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding , 2021, bioRxiv.

[5]  T. Schlick,et al.  Biomolecular modeling thrives in the age of technology , 2021, Nature Computational Science.

[6]  T. Fox,et al.  Protein-ligand free energies of binding from full-protein DFT calculations: convergence and choice of exchange-correlation functional. , 2021, Physical chemistry chemical physics : PCCP.

[7]  Haiyong Peng,et al.  Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 , 2021, PLoS pathogens.

[8]  A. Danchin,et al.  SARS‐CoV‐2 biology and variants: anticipation of viral evolution and what needs to be done , 2021, Environmental microbiology.

[9]  D. Stuart,et al.  The antigenic anatomy of SARS-CoV-2 receptor binding domain , 2021, Cell.

[10]  Rommie E. Amaro,et al.  A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors , 2021, Biophysical Journal.

[11]  M. Beltramello,et al.  Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity , 2021, Cell.

[12]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[13]  R. Najmanovich,et al.  Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants , 2020, bioRxiv.

[14]  R. Podgornik,et al.  Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: The case of spike protein of SARS-CoV-2 virus , 2020, Computational and Structural Biotechnology Journal.

[15]  J. Bloom,et al.  Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 , 2020, bioRxiv.

[16]  Lei Huang,et al.  AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics , 2020, bioRxiv.

[17]  Devjani Banerjee,et al.  Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19 , 2020, European Journal of Pharmacology.

[18]  Giampaolo Barone,et al.  Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches , 2020, Journal of proteome research.

[19]  U. Maulik,et al.  Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2 , 2020, Scientific Reports.

[20]  C. Rice,et al.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants , 2020, bioRxiv.

[21]  D. van der Spoel Systematic design of biomolecular force fields. , 2020, Current opinion in structural biology.

[22]  Neng Li,et al.  Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding. , 2020, Physical chemistry chemical physics : PCCP.

[23]  J. Dye,et al.  Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 , 2020, Science.

[24]  Pardis C Sabeti,et al.  Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant , 2020, bioRxiv.

[25]  Jesse D. Bloom,et al.  Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding , 2020, bioRxiv.

[26]  A. Warshel,et al.  Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV , 2020, The journal of physical chemistry. B.

[27]  Hongtao Zhang,et al.  Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease , 2020, Comput..

[28]  Thierry Deutsch,et al.  Flexibilities of wavelets as a computational basis set for large-scale electronic structure calculations. , 2020, The Journal of chemical physics.

[29]  Xifeng Lu,et al.  In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2 , 2020, Peptides.

[30]  David A. Scott,et al.  An open-source drug discovery platform enables ultra-large virtual screens , 2020, Nature.

[31]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[32]  L. Genovese,et al.  Complexity Reduction in Density Functional Theory Calculations of Large Systems: System Partitioning and Fragment Embedding. , 2019, Journal of chemical theory and computation.

[33]  Martin Zacharias,et al.  Computational prediction of protein–protein binding affinities , 2019, WIREs Computational Molecular Science.

[34]  Pnina Dauber-Osguthorpe,et al.  Biomolecular force fields: where have we been, where are we now, where do we need to go and how do we get there? , 2018, Journal of Computer-Aided Molecular Design.

[35]  J. Tuszynski,et al.  Software for molecular docking: a review , 2017, Biophysical Reviews.

[36]  Laura E Ratcliff,et al.  Complexity Reduction in Large Quantum Systems: Fragment Identification and Population Analysis via a Local Optimized Minimal Basis. , 2016, Journal of chemical theory and computation.

[37]  Thierry Deutsch,et al.  Challenges in large scale quantum mechanical calculations , 2016, 1609.00252.

[38]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[39]  Heather J. Kulik,et al.  How Large Should the QM Region Be in QM/MM Calculations? The Case of Catechol O-Methyltransferase , 2015, The journal of physical chemistry. B.

[40]  Stefan Goedecker,et al.  Accurate and efficient linear scaling DFT calculations with universal applicability. , 2015, Physical chemistry chemical physics : PCCP.

[41]  L. Dardenne,et al.  Receptor–ligand molecular docking , 2014, Biophysical Reviews.

[42]  S. Grimme,et al.  A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. , 2010, The Journal of chemical physics.

[43]  Gisbert Schneider,et al.  Virtual screening: an endless staircase? , 2010, Nature Reviews Drug Discovery.

[44]  Walter Thiel,et al.  QM/MM methods for biomolecular systems. , 2009, Angewandte Chemie.

[45]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[46]  Burke,et al.  Generalized Gradient Approximation Made Simple. , 1996, Physical review letters.